The principal goal of the Division of Nephrology is to excel in research, education and patient care related to diverse kidney disease. The current topics below illustrate the list of faculty members and their clinical, research and educational activities including publications and sponsored research performed during the past three years.
For questions about the current clinical studies please contact Char Klis at (414) 805-9075.
The primary goal of Kevin R. Regner, MD, MS, FASN, is to investigate the cellular, molecular, and genetic mechanisms involved in ischemic acute kidney injury (AKI) and kidney repair.
Samuel S. Blumenthal, MD, Barbara A. Bresnahan, MD, and Ashraf El-Meanawy, MD, PhD, are primarily involved in several areas of ongoing clinical research activity in subjects with CKD and ESRD.
The primary goal of Michael Yeboah, MD, PhD, is to investigate the cellular, molecular, and physiologic mechanisms of chronic renal injury.
Barbara A. Bresnahan, MD, Brahm Vasudev, MD, Ehab R. Saad, MD, FACP, FASN, MA, Talal Khairi, MD, FACP and Liliana Osadchuk, MD, have been involved in a number of pharmaceutical and NIH-sponsored clinical studies in the kidney transplant field.
The laboratory of Andrey Sorokin, PhD, is interested in multiple projects with focus on cell signaling as related to pathobiology of kidney disease.
The kidney stone research group at MCW consists of three full-time faculty, two physician scientists - Jack G. Kleinman, MD, and Jeffrey A. Wesson, MD, PhD - and one PhD investigator, Neil Mandel, PhD.
Medical College of Wisconsin
8701 Watertown Plank Road
Milwaukee, WI 53226
Directions & Maps